TSX gains after CPI shows US inflation rose 3%
Investing.com - J&J reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
J&J announced earnings per share of $2.67 on revenue of $23.43B. Analysts polled by Investing.com EPS of $2.59 on revenue of $23.69B.
J&J 's are up 3% and is trading at $177.66 , still down 3.55% from its 52 week high of $184.20 set on Monday, April 11, 2022.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings beat by UnitedHealth on Thursday, who reported EPS of $5.49 on revenue of $80.15B, EPS of $5.38 on revenue of $78,786M.
BioNTech had beat expectations on Wednesday, March 30, 2022 with first quarter EPS of $12.18 on revenue of $5.53B, for EPS of $7.44 on revenue of $3.92B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
